Harvard / Brigham / Anversa $10M FCA settlement (April 2017)

April 2017 — Harvard and Brigham and Women's Hospital paid $10 million to settle FCA claims related to the Anversa cardiac stem cell research program. 31 papers subsequently recommended for retraction in October 2018.

Use: E-0042, C-0025, M-0003 Term D.

Original whitepaper reference: [64]